Biliary atresia and pregnancy: puberty may be an important point for predicting the outcome

Tatsuo Kuroda1, Morihiro Saeki, Nobuyuki Morikawa

  • 1Department of Surgery, National Center for Child Health and Development, Tokyo 157-8535, Japan. kuroda-t@ncchd.go.jp

Insights

Biliary atresia patients with good liver function at puberty can safely experience pregnancy. Post-puberty liver function, not Kasai operation timing, predicts long-term outcomes and pregnancy safety.

Area of Science:

  • Hepatology
  • Pediatric Surgery
  • Reproductive Medicine

Background:

  • Biliary atresia is a severe neonatal liver disease.
  • Long-term outcomes and reproductive health in survivors are not well-defined.

Purpose of the Study:

  • To investigate the late clinical features of biliary atresia survivors.
  • To assess the safety and outcomes of pregnancy in women with a history of biliary atresia.

Main Methods:

  • Retrospective analysis of 49 adult biliary atresia patients (age > 15 years).
  • Review of clinical data, including liver function tests and pregnancy outcomes.
  • Comparison of liver function between patients with different clinical courses.

Main Results:

  • Six patients successfully delivered 7 newborns; 5 with native livers, 1 post-transplant.
  • Newborns were generally healthy, though often small-for-date.
  • Adult liver function at puberty, particularly enzyme levels, predicted later outcomes and pregnancy safety, independent of Kasai operation age.

Conclusions:

  • Liver function during puberty is a key predictor of long-term health and pregnancy safety in biliary atresia survivors.
  • Management strategies for these patients require reassessment after puberty.
  • Pregnancy can be a safe outcome for carefully selected patients with well-managed biliary atresia.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...